Tandem Labs has acquired PharmaKD, a Boston, MA-based division of Linden Technologies. Tandem will retain key personnel, intellectual property portfolios, proprietary informatics, scientific instruments, and 7,000-sq.-ft. of operational space from PharmaKD, which it will rename Tandem Labs – New England. Tandem will operate three facilities within the U.S.: Salt Lake City, New Jersey, and New England. Tandem’s expanded services will include metabolite profiling, identification, and q...